References
- Lokich, J J.; Bothe, A J.R.; Benotti, P.; Moore, C. Complications and management of implanted venous access catheters.J. Clin. Oncol. 1985, 3, 710–717. [PUBMED], [INFOTRIEVE], [CSA]
- Torramade, C J., Jr.; Hernandez, J.-L.; Pardo, F.; Benito, C.; Gonzalez, J.; Balen, E.; de Villa, V. The complications of central venous access systems: a study of 218 patients.Eur. J. Surg. 1993, 159, 323–327. [PUBMED], [INFOTRIEVE], [CSA]
- Harvey, W P.T.; Reed, K.; Moins, D.; Solenberger, R I. A prospective evaluation of the Port-A-Cath implantable venous access system in chronically ill adults and children.Surg. Gynecol. Obstet. 1989, 169, 495–500. [PUBMED], [INFOTRIEVE], [CSA]
- Wallace, J Z.P. Benefits, complications, and care of implantable infusion devices in 31 children with cancer.J. Pediatr. Surg. 1987, 22, 833–838. [PUBMED], [INFOTRIEVE], [CSA]
- Mueller, B U.S.J.; Callender, D P.E.; Marshall, D.; Gress, J.; Lango, D.; Norton, J.; Rubin, M.; Venzon, D.; Pizzo, P A. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients.J. Clin. Oncol. 1992, 10, 1943–1948. [PUBMED], [INFOTRIEVE], [CSA]
- Strum, S M.J.; Korn, A.; Joseph, C. Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system.J. Clin. Oncol. 1986, 4, 596–603. [PUBMED], [INFOTRIEVE], [CSA]
- Kock, H J.; Pietsch, M.; Krause, U.; Wilke, H.; Eigler, F W. Implantable vacular access systems: experience in 1500 patients with totally implanted central venous port systems.World J. Surg. 1998, 22, 12–16. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bern, M M.; Bothe, A., Jr.; Bistrian, B.; Batist, G.; Haywood, E.; Blackburn, G. Prophylaxis against central vein thrombosis with low-dose warfarin.Surgery 1983, 94, 78–83. [PUBMED], [INFOTRIEVE], [CSA]
- Mismetti, P.; Mille, D.; Laporte, S.; Charlet, V.; Buchmuller-Cordier, A.; Jacquin, J P.; Foumel, P.; Dutrey-Dupagne, C.; Decousus, H. CIP Study Group. Low-molecular-weight (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.Haematologica 2003, 88, 67–73. [PUBMED], [INFOTRIEVE], [CSA]
- Klert, C P.; Smorenburg, S M.; Buller, H R. Thrombosis prophylaxis in patients with a central venous cathete: a systemic review.Arch. Intern. Med. 2003, 163, 1913–1921. [CSA], [CROSSREF]
- Bern, M M.; Lokich, J J.; Wallach, S R.; Bothe, A., Jr.; Benotti, P N.; Arkin, C F.; Greco, F A.; Huberman, M.; Moore, C. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.Ann. Intern. Med. 1990, 112, 423–428. [PUBMED], [INFOTRIEVE], [CSA]